United Therapeutics

+$2.04 (+1.11%) Today
$0.00 (0.00%) As of 11:11 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UTHR and other ETFs, options, and stocks.

About UTHR

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma.

CEO
Martine A. Rothblatt
Employees
950
Headquarters
Silver Spring, Maryland
Founded
1996

UTHR Key Statistics

Market Cap
8.37B
Price-Earnings Ratio
17.92
Dividend Yield
—
Average Volume
376.43K
High Today
$187.00
Low Today
$182.38
Open Price
$182.60
Volume
279.66K
52 Week High
$216.90
52 Week Low
$115.53

UTHR News

BenzingaOct 18

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease

Motley Fool Shares of MannKind (NASDAQ: MNKD), a company working to develop inhaled therapeutics, were down 18% as of 11:59 a.m. EDT on Monday after an inspect
MarketWatchOct 18

United Therapeutics New Drug Application Declined Pending Inspection Issue

By Matt Grossman United Therapeutics Corp.'s Tyvaso drug application wasn't approved by the Food and Drug Administration, but the issue cited by the agency can

UTHR Earnings

$0.00
$1.36
$2.73
$4.09
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure